Back

Efficacy and Safety of Gene III L-ergothioneine Eye Care Solution in Dry Eye Syndrome: A Randomized, Self-Controlled Clinical Trial

2026-01-02 ophthalmology Title + abstract only
View on medRxiv
Show abstract

PurposeTo evaluate the efficacy and safety of Gene III L-ergothioneine (EGT) Eye Care Solution for alleviating ocular discomfort in patients with dry eye syndrome (DES). MethodsIn this single-center, randomized, open-label, self-controlled trial, 40 DES patients were randomly assigned in a 1:1 ratio to one of two treatment groups: Group 1 received the Gene III EGT Eye Care Wash Solution via an eye wash cup (5 mL/vial), and Group 2 received the same formulation as Gene III EGT Eye Care Drops Sol...

Predicted journal destinations